Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › ifetroban

ifetroban

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ifetroban

4 trials tracked of ifetroban.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4
  1. Phase 2 Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients Completed
  2. Phase 2 Thromboxane Receptor Antagonist to Improve Endothelial Function Completed
  3. Phase 2 Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Completed
  4. Phase 2 Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Phase 2 trial of oral ifetroban in DMD cardiomyopathy reports no safety results yet
Cardiology Phase II
Phase 2 trial of oral ifetroban in DMD cardiomyopathy reports no safety results yet Can a new pill help protect the hearts of boys with Duchenne muscular dystrophy?
A phase 2 randomized, double-blind, placebo-controlled trial evaluated low- and high-dose oral ifetroban in 46 males with DMD-associated car…
A new pill called ifetroban is being tested to safely treat heart weakness in boys with Duchenne muscular dystrophy, addressing a leading ca…
CT.gov Apr 2, 2026